Initially considered as genomic “junk”, long noncoding RNAs have gained attention as critical regulators of coding RNA and alternative splicing. LncRNAs have been associated with tumorigenesis, tumor progression and metastasis, thus emerging as a new class of promising cancer biomarkers and targets for therapeutic agents.
In this webinar, the speakers will:
- Demonstrate how transcriptome profiling can identify lncRNAs and novel cancer biomarkers
- Explain the role of lncRNAs in breast cancer progression and tumorigenesis
- Rebecca DeVaux, PhD, University at Albany State University of New York, USA
- Alfredo Hidalgo-Miranda, PhD, National Institute of Genomic Medicine, Mexico